MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lattard, V.
Right arrow Articles by Benoit, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lattard, V.
Right arrow Articles by Benoit, E.

Vol. 63, Issue 1, 253-261, January 2003

Cloning, Sequencing and Tissue Distribution of Rat Flavin-Containing Monooxygenase 4: Two Different Forms Are Produced by Tissue-Specific Alternative Splicing

Virginie Lattard, Christiane Longin-Sauvageon, and Etienne Benoit

Unité de Toxicologie et de Métabolisme Comparés des Xénobiotiques, Unité Mixte Recherche, Institut National de la Recherche Agronomique, et Direction Générale de l'Enseignement et de la Recherche, Ecole Nationale Vétérinaire de Lyon, Marcy l'étoile, France

The nucleotide sequence of rat flavin-containing monooxygenase 4 (FMO4) mRNA was obtained by reverse transcription-polymerase chain reaction (RT-PCR) and 5'/3' terminal extension. Complete cDNA was amplified, cloned, and sequenced from the mRNA obtained from rat kidney and brain. Two different transcripts (short and long) stemming from the splicing of an internal region of 189 bases pair, corresponding to exon 4 were identified. This alternative splicing seems to be specific of the brain. The long cDNA encodes a protein of 560 amino acids with a predicted molecular mass of 63,395 Da. The short cDNA encodes a protein of 497 amino acids with a predicted molecular mass of 55,871 Da. Both of these encoded sequences contain the NADPH- and FAD-binding sites and a hydrophilic carboxyl terminus. These sequences are 80 and 79% identical to the sequences of human and rabbit FMO4. By Northern blotting and/or RT-PCR, the long-form FMO4 mRNA was detected in the rat kidney, intestine, and liver and the short form particularly in the brain. For the first time, the expression of FMO4 protein was demonstrated. By Western blotting using the two different forms of FMO4 antibodies, a long FMO4 protein was detected in the rat kidney, whereas in the rat brain, only the short form of FMO4 was observed.


Copyright © 2003 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
R. M. Novick and A. A. Elfarra
Purification and Characterization of Flavin-Containing Monooxygenase Isoform 3 from Rat Kidney Microsomes
Drug Metab. Dispos., December 1, 2008; 36(12): 2468 - 2474.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
J. Zhang and J. R. Cashman
QUANTITATIVE ANALYSIS OF FMO GENE mRNA LEVELS IN HUMAN TISSUES
Drug Metab. Dispos., January 1, 2006; 34(1): 19 - 26.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. V. Pai, R. P. Kommaddi, S. J. Chinta, T. Mori, M. R. Boyd, and V. Ravindranath
A Frameshift Mutation and Alternate Splicing in Human Brain Generate a Functional Form of the Pseudogene Cytochrome P4502D7 That Demethylates Codeine to Morphine
J. Biol. Chem., June 25, 2004; 279(26): 27383 - 27389.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
V. Lattard, J. Zhang, and J. R. Cashman
Alternative Processing Events in Human FMO Genes
Mol. Pharmacol., June 1, 2004; 65(6): 1517 - 1525.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics